SCHEMBL26906805

SCHEMBL26906805

COc1cc(N2CCC(N3CCN(C)CC3)CC2)c(Cl)cc1Nc1ncc(Br)c(Nc2ccc3nccnc3c2P(C)C)n1

nearest known ligand 0.68

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 20/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22025925 0.93 EGFR (0.79) EGFR
SCHEMBL28541898 0.92 EGFR (0.68) EGFR
SCHEMBL28529250 0.92 EGFR (0.63) EGFR
SCHEMBL24953715 0.91 EGFR (0.67) EGFR
SCHEMBL22595134 0.91 EGFR (0.67) EGFR
SCHEMBL30019099 0.91 EGFR (0.67) EGFR
SCHEMBL22025902 0.91 EGFR (0.81) EGFR
SCHEMBL24953448 0.91 EGFR (0.67) EGFR
SCHEMBL28533927 0.90 EGFR (0.66) EGFR
SCHEMBL28538584 0.90 EGFR (0.66) EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4286376-A1 PYRIMIDINE DERIVATIVE HAVING PROTEIN KINASE INHIBITORY ACTIVITY, AND THERAPEUTIC PHARMACEUTICAL COMPOSITION COMPRISING SAME Therapex Co., Ltd. (KR) 2023-12-06 — — EP disclosed
Send feedback